|
|
|
|
| LEADER |
00964nam#a2200301#a#4500 |
| 001 |
OAGSID002781 |
| 003 |
OAG |
| 008 |
||||||| a |||| ||eng d |
| 020 |
# |
# |
|a 047150338X
|
| 040 |
# |
# |
|a OAG
|b spa
|c OAG
|
| 080 |
# |
# |
|a 574/578
|
| 092 |
# |
# |
|c 574/578 C982 P9451 v.1 ej.1
|
| 245 |
1 |
0 |
|a CURRENT protocolsin molecular biology
|
| 260 |
# |
# |
|a Canada :
|b John Wiley & Sons,
|c 1997, c1994
|
| 300 |
# |
# |
|a 3 v. :
|b il., tablas, diagr.
|
| 504 |
0 |
# |
|a Bibliografía: al final de cada tema
|
| 650 |
0 |
4 |
|a Biología Molecular
|
| 650 |
0 |
4 |
|a Laboratorios
|
| 650 |
0 |
4 |
|a Tecnología
|
| 929 |
# |
# |
|a DON
|9 29-9-97
|
| 930 |
# |
# |
|a 15889-1
|b 31
|d PRP
|
| 934 |
# |
# |
|a 15890-2
|
| 934 |
# |
# |
|a 15891-3
|
| 936 |
# |
# |
|a 11-97
|
| 952 |
# |
# |
|f DON
|w ||||||
|p OAG15889-1
|t v.31
|a OAG
|b OAG
|o 574/578 C982 P9451 V.1 EJ.1
|y IMP
|
| 952 |
# |
# |
|f DON
|w ||||||
|p OAG15890-2
|a OAG
|b OAG
|o 574/578 C982 P9451 V.2 EJ.1
|y IMP
|
| 952 |
# |
# |
|f DON
|w ||||||
|p OAG15891-3
|a OAG
|b OAG
|o 574/578 C982 P9451 V.3 EJ.1
|y IMP
|
| 999 |
# |
# |
|a Adriana
|
